MEDICINA
Departamento
Columbia University Medical Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Columbia University Medical Center (6)
2023
2022
-
Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
Leukemia, Vol. 36, Núm. 5, pp. 1432-1435
2021
-
Imetelstat achieves meaningful and durable transfusion independence in high transfusion–Burden patients with lower-risk myelodysplastic syndromes in a phase II study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 48-56
-
Undetectable NK Cells due to the FCGR3A Variant, L66H, Which May Not Be Directly Disease-Causing
Journal of Clinical Immunology
2020
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151
2014
-
International Myeloma Working Group recommendations for global myeloma care
Leukemia, Vol. 28, Núm. 5, pp. 981-992